General Anxiety Disorder Market Revenue To Accrue US$ 3,775 million by 2020

With the presence of a large pool of participants, the global market for general anxiety disorder is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). Johnson & Johnson, Pfizer Inc., Sanofi S.A., H. Lundbeck A/S, Eli Lilly and Company, and Merck & Co. are few key vendors of pharmaceutical drugs for general anxiety disorder across the world. These players are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the market study.

As estimated in this report, the Global general anxiety disorder market size stood at US$ 3,251 million in 2014. Witnessing a tremendous rise during the period from 2015 to 2020, the revenue in this market is expected to reach US$ 3,775 million by the end of the forecast period.

This review is based on a report by Zion Market Research, titled "General Anxiety Disorder Market by Therapeutics (Antidepressant, Benzodiazepines, and Others): U.S. Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast 2014 – 2020" report at https://www.zionmarketresearch.com/report/general-anxiety-disorder-market

Rising Incidence Of Anxiety Disorders And Depression To Impel Market Growth

“Surging geriatric population prone to anxiety disorders along with the introduction of new therapies for treating the ailment is predicted to drive general anxiety disorder market expansion,” says the author of this study. In addition to this, the introduction of new therapies used for treating general anxiety disorders are also expected to succor the market trends.

Today, the general anxiety disorder market is witnessing a decline, subject to a low supply of new drugs, the expiry of key antidepressant drug patents, and a rise in the number of cost-effective generic drugs in the market.

Prevalence Of Anxiety-related Ailments To Help North America Dominate Regional Market

Regionally, North America has been leading the global general anxiety disorder market and is predicted to maintain its domination over the next few years, states market study. In 2014, North America evolved as the key regional market, owing to large population infected as a result of depression & anxiety disorders. The presence of large & small pharmaceutical companies in North America is another significant factor that is supporting the growth of this regional market.

The U.S. accounts for a major share of the anxiety disorder therapeutics sector across the globe and can be credited for the dominant position of North America across the general anxiety disorder market. The presence of both large

Furthermore, as per the reports of the anxiety and depression association of America, general anxiety disorder severely affects 3.1% of the population in the U.S. This is anticipated to create lucrative opportunities for the market players to explore U.S. general anxiety disorder market as well as establish a strong presence in the region.

The global general anxiety disorder market is segmented as follows:

By Therapeutics

• Antidepressant
• Benzodiazepines
• Others (Buspirone)

By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com